JBIO Latest Press Releases

-- November 3, 2026 --

Jade Biosciences to Participate in Upcoming Conferences Globe Newswire 7:00 AM

-- October 21, 2026 --

Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026 Globe Newswire 7:00 AM

-- September 30, 2026 --

Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN- Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026 Globe Newswire 7:00 AM

-- September 1, 2026 --

Jade Biosciences to Participate in Upcoming Conferences Globe Newswire 7:00 AM

-- August 10, 2026 --

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- June 26, 2026 --

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors Globe Newswire 7:00 AM

-- June 5, 2026 --

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes